Infinity Pharma: JMP Securities Healthcare Conference (Infinity Pharmaceuticals) - Jul 10, 2013 - Anticipated composition of matter patent expiry for NSCLC in 2024; Anticipated methods of use patent expiry for NSCLC in 2024
Anticipated patent expiry • Non Small Cell Lung Cancer
|